This work is licensed under the Creative Commons Attribution 4.0 International License.
Berry GT. Classic Galactosemia and Clinical Variant Galactosemia.In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993-2018. 2000 Feb 4 [updated 2017 Mar 9].BerryGTInAdamMPArdingerHHPagonRAWallaceSEBeanLJHStephensKAmemiyaAeditorsGeneReviews®Seattle (WA)University of Washington, Seattle199320182000Feb 4 [updated 2017 Mar 9]Search in Google Scholar
Beutler F, Baluda M. A simple spot screening test for galactosemia. J Lab Clin Med. 1966;137-141.BeutlerFBaludaMA simple spot screening test for galactosemia1966137141Search in Google Scholar
Clouds over galactosaemia.[No authors listed] Lancet. 1982 Dec 18;2(8312):1379-1380.1982Dec 18283121379138010.1016/S0140-6736(82)91278-8Search in Google Scholar
Kaufman FR, Kogut MD, Donnell GN, Goebelsmann U, March C, Koch R. Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med. 1981;304:994–998.KaufmanFRKogutMDDonnellGNGoebelsmannUMarchCKochRHypergonadotropic hypogonadism in female patients with galactosemia198130499499810.1056/NEJM198104233041702Search in Google Scholar
Schweitzer S, Shin Y, Jakobs C, Brodehl J. Long-term outcome in 134 patients with galactosaemia. Eur J Pediatr. 1993;152:36-43.SchweitzerSShinYJakobsCBrodehlJLong-term outcome in 134 patients with galactosaemia1993152364310.1007/BF02072514Search in Google Scholar
Kaufman FR, Reichardt JK, Ng WG, Xu YK, Manis FR, McBride-Chang C, et al. Correlation of cognitive, neurologic, and ovarian outcome with the Q188R mutation of the galactose-1-phosphate uridyltransferase gene. J Pediatr. 1994;125:225–227.KaufmanFRReichardtJKNgWGXuYKManisFRMcBride-ChangCet alCorrelation of cognitive, neurologic, and ovarian outcome with the Q188R mutation of the galactose-1-phosphate uridyltransferase gene199412522522710.1016/S0022-3476(94)70197-0Search in Google Scholar
Bosch AM, Grootenhuis MA, Bakker HD, Heijmans HSA, Wijburg FA, Last BF. Living with classical galactosemia: health-related quality of life consequences. Pediatrics 2004;113:e423-8. 56.BoschAMGrootenhuisMABakkerHDHeijmansHSAWijburgFALastBFLiving with classical galactosemia: health-related quality of life consequences2004113e42385610.1542/peds.113.5.e42315121984Search in Google Scholar
Waisbren SE, Potter NL, Gordon CM, Green RC, Greenstein P, Gubbels CS, et al. The adult galactosemic phenotype. J Inherit Metab Dis. 2012;35:279-286.WaisbrenSEPotterNLGordonCMGreenRCGreensteinPGubbelsCSet alThe adult galactosemic phenotype20123527928610.1007/s10545-011-9372-y364177121779791Search in Google Scholar
Coss KP, Doran PP, Owoeye C, et al. Classical Galactosaemia in Ireland: incidence, complications and outcomes of treatment. J Inherit Metab Dis. 2013;36:21-27.CossKPDoranPPOwoeyeCet alClassical Galactosaemia in Ireland: incidence, complications and outcomes of treatment201336212710.1007/s10545-012-9507-922870861Search in Google Scholar
Berry GT, Moate PJ, Reynolds RA, et al. The rate of de novo galactose synthesis in patients with galactose-1-phosphate uridyltransferase deficiency. Mol Genet Metab. 2004 Jan;81(1):22-30.BerryGTMoatePJReynoldsRAet alThe rate of de novo galactose synthesis in patients with galactose-1-phosphate uridyltransferase deficiency2004Jan811223010.1016/j.ymgme.2003.08.02614728988Search in Google Scholar
Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organization; 1968.WilsonJMGJungnerGGenevaWorld Health Organization;1968Search in Google Scholar
Pyhtila BM, Shaw KA, Neumann SE, Fridovich-Keil JL. Newborn Screening for Galactosemia in the United States: Looking Back, Looking Around, and Looking Ahead JIMD Rep. 2015; 15:79-93.PyhtilaBMShawKANeumannSEFridovich-KeilJLNewborn Screening for Galactosemia in the United States: Looking Back201515799310.1007/8904_2014_302441301524718839Search in Google Scholar
Welling L, Boelen A, Derks TG et al. Nine years of newborn screening for classical galactosemia in the Netherlands: Effectiveness of screening methods, and identification of patients with previously unreported phenotypes. Mol Genet Metab. 2017 Mar;120(3):223-228.WellingLBoelenADerksTGet alNine years of newborn screening for classical galactosemia in the Netherlands: Effectiveness of screening methods, and identification of patients with previously unreported phenotypes2017Mar120322322810.1016/j.ymgme.2016.12.01228065439Search in Google Scholar
Hewlett J, Waisbren SE. A review of the psychosocial effects of false-positive results on parents and current communication practices in newborn screening. J Inherit Metab Dis 2006;29:677-682. 11.HewlettJWaisbrenSEA review of the psychosocial effects of false-positive results on parents and current communication practices in newborn screening2006296776821110.1007/s10545-006-0381-1Search in Google Scholar
Ohlsson A, Guthenberg C, von Döbeln U. Galactosemia screening with low false-positive recall rate: the Swedish experience. JIMD Rep. 2012;2:113-117.OhlssonAGuthenbergCvonDöbeln U.Galactosemia screening with low false-positive recall rate: the Swedish experience2012211311710.1007/8904_2011_59Search in Google Scholar
Welling L, Bernstein LE, Berry GT et al. International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up. J Inherit Metab Dis. 2017;40(2):171-176.WellingLBernsteinLEBerryGTet alInternational clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up201740217117610.1007/s10545-016-9990-5530641927858262Search in Google Scholar
Schweitzer-Krantz S. Early diagnosis of inherited metabolic disorders towards improving outcome: the controversial issue of galactosemia. Eur J Pediatr. 2003;162:S50-S53.Schweitzer-KrantzS.Early diagnosis of inherited metabolic disorders towards improving outcome: the controversial issue of galactosemia2003162S50S5310.1007/s00431-003-1352-2Search in Google Scholar
Hughes J, Ryan S, Lambert D, et al (2009) Outcomes of siblings with classical galactosemia. J Pediatr. 154:721726.HughesJRyanSLambertDet al2009Outcomes of siblings with classical galactosemia15472172610.1016/j.jpeds.2008.11.052Search in Google Scholar
Padilla CD, Dans LF, Estrada SC, Tamondong MR Jr, Laceste JJ, Bernal RM. Cost-benefit analysis of newborn screening for galactosemia in the Philippines. Southeast Asian J Trop Med Public Health. 2003;34 Suppl 3:215-220.PadillaCDDansLFEstradaSCTamondongMR JrLacesteJJBernalRM.Cost-benefit analysis of newborn screening for galactosemia in the Philippines200334 Suppl3215220Search in Google Scholar
Camelo JS Jr, Fernandes MI, Maciel LM, et al. Galactosaemia in a Brazilian population: high incidence and cost-benefit analysis. J Inherit Metab Dis. 2009 Dec;32 Suppl 1:S141-149.CameloJS JrFernandesMIMacielLMet alGalactosaemia in a Brazilian population: high incidence and cost-benefit analysis2009Dec;32 Suppl1S14114910.1007/s10545-009-1112-1Search in Google Scholar
Hatam N, Askarian M, Shirvani S, Siavashi E. Neonatal Screening: Cost-utility Analysis for Galactosemia. Iran J Public Health. 2017 Jan;46(1):112-119.HatamNAskarianMShirvaniSSiavashiENeonatal Screening: Cost-utility Analysis for Galactosemia2017Jan461112119Search in Google Scholar
Varela-Lema L, Paz-Valinas L, Atienza-Merino G, Zubizarreta-Alberdi R, Villares RV, López-García M. Appropriateness of newborn screening for classic galactosaemia: a systematic review. J Inherit Metab Dis 2016;1-17.Varela-LemaLPaz-ValinasLAtienza-MerinoGZubizarreta-AlberdiRVillaresRVLópez-GarcíaM.Appropriateness of newborn screening for classic galactosaemia: a systematic review201611710.1007/s10545-016-9936-ySearch in Google Scholar
Lak R, Yazdizadeh B, Davari M, Nouhi M, Kelishadi R. Newborn screening for galactosaemia. Cochrane Database Syst Rev. 2017 Dec 23;12:CD012272.LakRYazdizadehBDavariMNouhiMKelishadiRNewborn screening for galactosaemia2017Dec 2312CD01227210.1002/14651858.CD012272.pub2Search in Google Scholar
Bożkowa K et al. Neonatal screening, Clinical and Biochemical Aspects. Bioch Med. 1977;17:24-30.BożkowaKet alNeonatal screening, Clinical and Biochemical Aspects197717243010.1016/0006-2944(77)90006-0Search in Google Scholar
Bożkowa K, Cabalska B, Radomyska B, Ołtarzewski M, Lenartowska I. Ocena przydatności badań przesiewowych u noworodków w świetle 35 lat doświadczeń własnych. Medycyna Wieku Rozwojowego 1999;III, 4:529-559.BożkowaKCabalskaBRadomyskaBOłtarzewskiMLenartowskaI.Ocena przydatności badań przesiewowych u noworodków w świetle 35 lat doświadczeń własnych1999III4529559Search in Google Scholar
Chojnacki T, Sawicka T. Nowa metoda izotopowa w diagnostyce galaktozemii. Pol Tyg Lek. 1969;XXIV:625.ChojnackiTSawickaTNowa metoda izotopowa w diagnostyce galaktozemii1969XXIV625Search in Google Scholar
Grodzka Z, Zbieg-Sendecka E, Cabalska B. Wczesna diagnostyka galaktozemii. Ped Pol. 1979;LIV, 5.GrodzkaZZbieg-SendeckaECabalskaBWczesna diagnostyka galaktozemii1979LIV5Search in Google Scholar
Bożkowa K, Cabalska B, Duczyńska N, Grodzka Z, Sendecka E, Nowakowska A, Lenartowska I, Kasperska-Dworak A, Helwich E. Postępy we wczesnym rozpoznawaniu genetycznie uwarunkowanych zaburzeń metabolicznych. Problemy Medycyny Wieku Rozwojowego 1980;10:69-85.BożkowaKCabalskaBDuczyńskaNGrodzkaZSendeckaENowakowskaALenartowskaIKasperska-DworakAHelwichEPostępy we wczesnym rozpoznawaniu genetycznie uwarunkowanych zaburzeń metabolicznych1980106985Search in Google Scholar
Radomyska B, Mańkowski T. Ocena odległych wyników leczenia galaktozemii. Ped Pol. 1994;5:345.RadomyskaBMańkowskiTOcena odległych wyników leczenia galaktozemii19945345Search in Google Scholar
Welling L, Bernstein LE, Berry GT, Burlina AB, Eyskens F, Gautschi M, Grünewald S, Gubbels CS, Knerr I, Labrune P, van der Lee JH, MacDonald A, Murphy E, Portnoi PA, Õunap K, Potter NL, Rubio-Gozalbo ME, Spencer JB, Timmers I, Treacy EP, Van Calcar SC, Waisbren SE, Bosch AM. International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up. J Inherit Metab Dis. 2017;40(2):171-176.WellingLBernsteinLEBerryGTBurlinaABEyskensFGautschiMGrünewaldSGubbelsCSKnerrILabrunePvander Lee JHMacDonaldAMurphyEPortnoiPAÕunapKPotterNLRubio-GozalboMESpencerJBTimmersITreacyEPVanCalcar SCWaisbrenSEBoschAMInternational clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up201740217117610.1007/s10545-016-9990-5Search in Google Scholar